We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

PGNY:NASDAQProgyny, Inc. analysis

Data as of Oct 19, 2026 - not real-time

Latest price
$27.58
Risk: medium
6/10Medium risk

Summary

Progyny, Inc. is priced at $27.58 and its moving averages line up in bullish order, the shorter sitting above the longer. Over a rolling month the price has gained 6.3%. With RSI at 55.9 the momentum picture is neutral, alongside a bullish MACD signal. The recent range runs from support at $24.33 up to resistance at $28.82.
The shares look fair, trading on 30.0 times earnings in line with a sector average of 31.3. The average analyst target implies 24.8% above today's level. Revenue is growing at 5.3% on a 6.0% profit margin.
The composite risk read is 6/10, putting it in elevated territory. With 30-day volatility of 32.7%, a beta of 0.34 and a maximum drawdown of 42.6%, position sizing matters here. The wider market backdrop reads extreme greed at 90 on the fear-greed composite.
All three time horizons resolve to buy, carrying 6/10 conviction.

Top market events

  • Let’s dig into the relative performance of Progyny NASDAQ:PGNY and its peers as we unravel the now-completed Q2...
  • Let’s dig into the relative performance of Progyny NASDAQ:PGNY and its peers as we unravel the now-completed Q2...
  • Second-quarter revenue reached USD 350.51 million, up 5.30 percent year over year. Progyny stock was

Market outlook

Short term

< 1 year

Positive

Model confidence7/107 out of 10

Key factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 24.28
  • MACD momentum is positive

Medium term

1–3 years

Positive

Model confidence6/106 out of 10

Key factors

  • Short-term moving averages stacked above long-term ones
  • P/E of 30.0 versus sector average of 31.3
  • Trading above the 200-day average of 24.28

Long term

> 3 years

Positive

Model confidence6/106 out of 10

Key factors

  • P/E of 30.0 versus sector average of 31.3
  • Analyst targets imply +24.8% versus the current price
  • Return on equity of 16.2%

Key metrics

Financial health

Revenue Growth5.30%
Profit Margin6.00%
P/E Ratio30.0
ROE16.24%
ROA10.14%
Debt/Equity5.95
P/B Ratio4.7
Op. Cash Flow$201.2M
Free Cash Flow$196.5M
Industry P/E31.3

Technical analysis

TrendBullish
RSI55.9
Support$24.33
Resistance$28.82
MA 20$26.46
MA 50$26.44
MA 200$24.28
MACDBullish
VolumeDecreasing
Fear & Greed Index89.88

Valuation

Fair Value$41.59
Target Price$34.42
Upside/Downside24.79%
GradeFair
TypeGrowth

Risk assessment

Beta0.34
Volatility32.74%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.